Literature DB >> 21660149

Regulation of DREAM Expression by Group I mGluR.

Jinu Lee1, Insook Kim, So Ra Oh, Suk Jin Ko, Mi Kyung Lim, Dong Goo Kim, Chul Hoon Kim.   

Abstract

DREAM (downstream regulatory element antagonistic modulator) is a calcium-binding protein that regulates dynorphin expression, promotes potassium channel surface expression, and enhances presenilin processing in an expression level-dependent manner. However, no molecular mechanism has yet explained how protein levels of DREAM are regulated. Here we identified group I mGluR (mGluR1/5) as a positive regulator of DREAM protein expression. Overexpression of mGluR1/5 increased the cellular level of DREAM. Up-regulation of DREAM resulted in increased DREAM protein in both the nucleus and cytoplasm, where the protein acts as a transcriptional repressor and a modulator of its interacting proteins, respectively. DHPG (3,5-dihydroxyphenylglycine), a group I mGluR agonist, also up-regulated DREAM expression in cortical neurons. These results suggest that group I mGluR is the first identified receptor that may regulate DREAM activity in neurons.

Entities:  

Keywords:  Calcium; DREAM; Group I mGluR; Pain; mGluR1; mGluR5

Year:  2011        PMID: 21660149      PMCID: PMC3104204          DOI: 10.4196/kjpp.2011.15.2.95

Source DB:  PubMed          Journal:  Korean J Physiol Pharmacol        ISSN: 1226-4512            Impact factor:   2.016


  25 in total

Review 1.  Group I metabotropic glutamate receptor signalling and its implication in neurological disease.

Authors:  Fabiola M Ribeiro; Maryse Paquet; Sean P Cregan; Stephen S G Ferguson
Journal:  CNS Neurol Disord Drug Targets       Date:  2010-11       Impact factor: 4.388

Review 2.  Potential psychiatric applications of metabotropic glutamate receptor agonists and antagonists.

Authors:  John H Krystal; Sanjay J Mathew; D Cyril D'Souza; Amir Garakani; Handan Gunduz-Bruce; Dennis S Charney
Journal:  CNS Drugs       Date:  2010-08       Impact factor: 5.749

3.  Activation of metabotropic glutamate receptor 5 in the amygdala modulates pain-like behavior.

Authors:  Benedict J Kolber; Michael C Montana; Yarimar Carrasquillo; Jian Xu; Stephen F Heinemann; Louis J Muglia; Robert W Gereau
Journal:  J Neurosci       Date:  2010-06-16       Impact factor: 6.167

Review 4.  Mechanism-based approaches to treating fragile X.

Authors:  Gül Dölen; Randall L Carpenter; Timothy D Ocain; Mark F Bear
Journal:  Pharmacol Ther       Date:  2010-03-18       Impact factor: 12.310

5.  Spinal Metabotropic Glutamate Receptors (mGluRs) are Involved in the Melittin-induced Nociception in Rats.

Authors:  Chul Hyun Cho; Hong Kee Shin
Journal:  Korean J Physiol Pharmacol       Date:  2008-10-31       Impact factor: 2.016

Review 6.  Metabotropic glutamate receptors: physiology, pharmacology, and disease.

Authors:  Colleen M Niswender; P Jeffrey Conn
Journal:  Annu Rev Pharmacol Toxicol       Date:  2010       Impact factor: 13.820

Review 7.  When a G protein-coupled receptor does not couple to a G protein.

Authors:  Yutong Sun; Deirdre McGarrigle; Xin-Yun Huang
Journal:  Mol Biosyst       Date:  2007-10-04

8.  Calsenilin: a calcium-binding protein that interacts with the presenilins and regulates the levels of a presenilin fragment.

Authors:  J D Buxbaum; E K Choi; Y Luo; C Lilliehook; A C Crowley; D E Merriam; W Wasco
Journal:  Nat Med       Date:  1998-10       Impact factor: 53.440

9.  Calmodulin dynamically regulates the trafficking of the metabotropic glutamate receptor mGluR5.

Authors:  Jeong Ho Lee; Jinu Lee; Kyu Yeong Choi; Regine Hepp; Jae-Youn Lee; Mi Kyung Lim; Mayumi Chatani-Hinze; Paul A Roche; Dong Goo Kim; Young Soo Ahn; Chul Hoon Kim; Katherine W Roche
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-20       Impact factor: 11.205

10.  Metabotropic glutamate receptor 5 modulates nociceptive plasticity via extracellular signal-regulated kinase-Kv4.2 signaling in spinal cord dorsal horn neurons.

Authors:  Hui-Juan Hu; Benedict J Alter; Yarimar Carrasquillo; Chang-Sheng Qiu; Robert W Gereau
Journal:  J Neurosci       Date:  2007-11-28       Impact factor: 6.167

View more
  2 in total

1.  TRPC-Mediated Current Is Not Involved in Endocannabinoid-Induced Short-Term Depression in Cerebellum.

Authors:  Wonseok Chang; Joo Min Park; Jun Kim; Sang Jeong Kim
Journal:  Korean J Physiol Pharmacol       Date:  2012-04-24       Impact factor: 2.016

2.  The Effects of Pre-emptive Administration of Ketamine and norBNI on Pain Behavior, c-Fos, and Prodynorphin Protein Expression in the Rat Spinal Cord after Formalin-induced Pain Is Modulated by the DREAM Protein.

Authors:  Idris Long; Rapeah Suppian; Zalina Ismail
Journal:  Korean J Pain       Date:  2013-07-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.